×

Odd timing for J&J's proposed takeover of Actelion due to Trump: Pro

Friday, 25 Nov 2016 | 3:57 AM ET

Alex Tarrant, assistant editor at Dealreporter Europe, weighs in on Johnson & Johnson's proposed acquisition of Swiss biotechnology company Actelion.